Abstract:Background: The neuromuscular junction (NMJ) is a peripheral synapse critical to muscle contraction. Like acetylcholine receptors (AChRs), many essential proteins of NMJ are extremely concentrated at the postjunctional membrane. However, the mechanisms of synapse-specific concentration are not well understood; furthermore, it is unclear whether signaling molecules critical to NMJ formation and maintenance are also locally transcribed. Results: We studied the β-gal activity encoded by a lacZ cassette driven by the promoter of the Lrp4 gene. As reported for Lrp4 mRNA, β-gal was in the central region in embryonic muscles and at the NMJ after its formation. However, β-gal was no longer in the central areas of muscle fibers in Lrp4 or MuSK mutant mice, indicating a requirement of Lrp4/MuSK signaling. This phenotype could be rescued by transgenic expression of LRP4 with a transmembrane domain but not soluble ECD in Lrp4 mutant mice. β-gal and AChR clusters were distributed in a broader region in lacZ/ECD than that of heterozygous lacZ/+ mice, indicating an important role of the transmembrane domain in Lrp4 signaling. Synaptic β-gal activity became diffused after denervation or treatment with µ-conotoxin, despite its mRNA was increased, indicating synaptic Lrp4 mRNA enrichment requires muscle activity. β-gal was also diffused in aged mice but became re-concentrated after muscle stimulation. Finally, Lrp4 mRNA was increased in C2C12 myotubes by Wnt ligands in a manner that could be inhibited by RKI-1447, an inhibitor of ROCK in Wnt non-canonical signaling. Injecting RKI-1447 into muscles of adult mice diminished Lrp4 synaptic expression. Conclusions: This study demonstrates that synapse-specific enrichment of Lrp4 mRNA requires a coordinated interaction between Lrp4/MuSK signaling, muscle activity, and Wnt non-canonical signaling. Thus, the study provides a new mechanism for Lrp4 mRNA enrichment. It also provides a potential target for the treatment of NMJ aging and other NMJ-related diseases.

LRP4 in Neuromuscular Junction and Bone Development and Diseases.

LRP4-related signalling pathways and their regulatory role in neurological diseases

Mutant LRP6 Impairs Endothelial Cell Functions Associated with Familial Normolipidemic Coronary Artery Disease.

Lrp4 In Osteoblasts Suppresses Bone Formation And Promotes Osteoclastogenesis And Bone Resorption

LRP4 is critical for neuromuscular junction maintenance.

Distinct Roles of Muscle and Motoneuron LRP4 in Neuromuscular Junction Formation

LRP5, Bone Mass Polymorphisms and Skeletal Disorders

LGR4: A New Receptor Member in Endocrine and Metabolic Diseases

Low-density lipoprotein receptor-related protein-1 (LRP1) in the glial lineage modulates neuronal excitability

Ablation of Lrp4 in Schwann Cells Promotes Peripheral Nerve Regeneration in Mice.

LDL receptor-related protein 1 and its interacting partners in tissue homeostasis

Synapse-specific Lrp4 mRNA enrichment requires Lrp4/MuSK signaling, muscle activity and Wnt non-canonical pathway

LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption

LRP4 mediated synaptic plasticity in the piriform cortex

Novel insights into the multifaceted and tissue-specific roles of the endocytic receptor LRP1

Increasing LRP4 diminishes neuromuscular deficits in a mouse model of Duchenne muscular dystrophy

Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6) Is a Novel Nutritional Therapeutic Target for Hyperlipidemia, Non-Alcoholic Fatty Liver Disease, and Atherosclerosis

Signaling through LRP1: Protection from atherosclerosis and beyond

Elucidating the Binding Mechanism of LPA Species and Analogs in an LPA4 Receptor Homology Model

Multifaceted effects of LRP6 in cancer: exploring tumor development, immune modulation and targeted therapies